Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53-Reference-Cited by-同舟云学术

Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53

Published:2001-01 Issue:4 Volume:20 Page:514-522
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Fillippovich Igor,Sorokina Natasha,Gatei Magtouf,Haupt Ygal,Hobson Karen,Moallem Eli,Spring Kevin,Mould Michelle,McGuckin Michael A,Lavin Martin F,Khanna Kum Kum

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1204118.pdf

Reference43 articles.

1. Allday MJ, Crawford DH and Thomas JA. . 1993 J. Gen. Virol. 74: 361–369.

2. Allday MJ, Inman GJ, Crawford DH and Farrell PJ. . 1995 EMBO J. 14: 4994–5005.

3. Bargonetti J, Reynisdottir I, Friedman PN and Prives C. . 1992 Genes Dev. 6: 1886–1898.

4. Casciano I, Ponzoni M, Cunsolo CL, Tonini GP and Romani M. . 1999 Cell Death Differ. 6: 391–393.

5. Debbas M and White E. . 1993 Genes Dev. 7: 546–554.

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p53 Family in Resistance to Targeted Therapy of Melanoma;International Journal of Molecular Sciences;2022-12-21

2. Tissue-specific expression of p73 and p63 isoforms in human tissues;Cell Death & Disease;2021-07-27

3. p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies;Cancers;2021-06-09

4. RNA splicing alteration in the response to platinum chemotherapy in ovarian cancer: A possible biomarker and therapeutic target;Medicinal Research Reviews;2020-10-14

5. Clinical implications of the deregulated TP73 isoforms expression in cancer;Clinical and Translational Oncology;2017-12-11